Arcosa (ACA) Cash & Equivalents (2017 - 2026)

Arcosa (ACA) has 10 years of Cash & Equivalents data on file, last reported at $153.2 million in Q1 2026.

• Quarterly Cash & Equivalents fell 8.76% year-over-year to $153.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.2 million (down 8.76% YoY) and the FY2025 annual result came in at $214.6 million, up 14.58% from the prior year.
• Cash & Equivalents declined to $153.2 million in Q1 2026 per ACA's latest filing, from $214.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $756.8 million in Q3 2024, with the low at $77.0 million in Q2 2022.
• Average Cash & Equivalents over 5 years is $189.1 million, with a median of $160.4 million recorded in 2022.
• Year-over-year, Cash & Equivalents surged 387.31% in 2024 and tumbled 70.93% in 2025.
• Arcosa's Cash & Equivalents stood at $160.4 million in 2022, then tumbled by 34.66% to $104.8 million in 2023, then jumped by 78.72% to $187.3 million in 2024, then increased by 14.58% to $214.6 million in 2025, then slipped by 28.61% to $153.2 million in 2026.
• Business Quant data shows ACA's Cash & Equivalents at $153.2 million in Q1 2026, $214.6 million in Q4 2025, and $220.0 million in Q3 2025.